Pharmacy News

Risk for Severe COVID-19 Increases With BMI Above 23

TUESDAY, May 4, 2021 — The risk for severe COVID-19 leading to hospital admission and death is increased at a body mass index (BMI) of more than 23 kg/m2, according to a study published online April 28 in The Lancet Diabetes & Endocrinology.

Min Gao, from the University of Oxford in the United Kingdom, and colleagues conducted a community-based cohort study using deidentified patient-level data to examine the association of obesity with adverse outcomes after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Data were included for 6,910,695 eligible individuals (mean BMI, 26.78 kg/m2).

The researchers found that 0.20 percent of the eligible individuals were admitted to the hospital, 0.02 percent were admitted to an intensive care unit (ICU), and 0.08 percent died after a positive SARS-CoV-2 test. A J-shaped association was identified between BMI and admission to the hospital for COVID-19 and death (adjusted hazard ratios per kg/m2 from the nadir at BMI of 23 kg/m2, 1.05 and 1.04, respectively); across the whole BMI range, there was a linear association with ICU admission (hazard ratio, 1.10). There was a significant interaction between BMI and age and ethnicity; above BMI 23 kg/m2, hazard ratios increased per kg/m2 for younger people (adjusted hazard ratio for hospital admission, 1.09 versus 1.01 for those aged 20 to 39 versus 80 to 100 years) and for Blacks versus Whites (hazard ratios, 1.07 versus 1.04).

“We don’t yet know that weight loss specifically reduces the risk of severe COVID-19 outcomes, but it is highly plausible, and will certainly bring other health benefits,” a coauthor said in a statement.

Abstract/Full Text

Editorial

© 2021 HealthDay. All rights reserved.

Further Support and Information on COVID-19

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Ad Block Detected

Welcome to Mediexpose, Please support our journalism by allowing ads. With support from readers like you, we can continue to deliver the best. You can support us free by simply allowing ads.